Chinese Medicine Combined With EGFR-TKIs Prolongs Progression-Free Survival and Overall Survival of Non-small Cell Lung Cancer (NSCLC) Patients Harboring EGFR Mutations, Compared With the Use of TKIs Alone

Objective: To explore the efficacy comparison between epidermal growth factor receptor–tyrosine kinase inhibitors (EGFR-TKIs) combined with traditional Chinese medicine (TCM) and single EGFR-TKIs for advanced non-small cell lung cancer (NSCLC). Methods: A total of 91 NSCLC patients with EGFR mutatio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Public Health
Main Authors: Wang, Yujia, Wu, Guoyu, Li, Ru, Luo, Yingzhe, Huang, Xingmei, He, Lifang, Zhong, Huihui, Xiong, Shaoquan
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Public Health
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8249768/
https://ncbi.nlm.nih.gov/pubmed/34222178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fpubh.2021.677862
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados